A Prospective Clinical Study Evaluating the Harvesting of Micografts

Status Completed

Clinical Trial Summary

ART (Autologous Regeneration of Tissue) is a revolutionary technology for harvesting skin without the drawbacks of conventional grafting. This innovative system allows the clinician to collect hundreds of microcolumns of full-thickness skin tissue and apply them directly to the wound site. It can all be done in an outpatient setting with minimized donor site concerns.

Clinical Trial Description

Millions of Americans suffer from acute and hard-to-heal chronic wounds. The National Institutes of Health estimates that 3% of the U.S. population over the age of 65 has an open wound. As the population ages in concert with an increased incidence of diabetes and obesity, the problem will intensify. A recent article suggests that the financial burden of wound care is approaching 100 billion dollars. Despite the gravity of the problem and the number of patients afflicted, open wounds can take weeks, months or even years to heal. The search for interventions that promote healing, reduce suffering and enhance quality of life continues as does the need to address the underlying issues that disrupt the wound healing process. Countless hours are spent treating chronic wounds (diabetic ulcers, venous ulcers, pressure injuries). Called the "silent epidemic," chronic wounds often result in infection, disability and sometimes amputation. Crafting a treatment plan that addresses the individual needs of each wound and each patient, hinges on managing the underlying issues that can disrupt healing and increase healthcare costs. Innovation in wound bed preparation and tissue regeneration bring new hope for these patients in the form of more effective wound closure, improved quality of life and reduced costs. Autologous skin grafting is the gold standard for covering areas of skin loss.4 However, traditional grafting is limited by accessibility issues and donor site complications-pain, risk of infection, scarring. ART (Autologous Regeneration of Tissue) is a revolutionary technology for harvesting skin without the drawbacks of conventional grafting. This innovative system allows the clinician to collect hundreds of microcolumns of full-thickness skin tissue and apply them directly to the wound site. It can all be done in an outpatient setting with minimized donor site concerns. ;

Study Design

Related Conditions & MeSH terms

Chronic Wound

Clinical Trial Details

NCT number	NCT05076578
Study type	Interventional
Source	SerenaGroup, Inc.
Contact
Status	Completed
Phase	N/A
Start date	September 13, 2021
Completion date	February 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04887688` - Exciflex for Chronic Wound Therapy	N/A
Terminated	`NCT03738579` - Evaluating Wound Healing With Next Science Gel & Wash.	N/A
Enrolling by invitation	`NCT06444035` - Extended Therapeutic Effect of 35kDa Hyaluronan Fragment Injection in Patients With Chronic Pain Caused by Myofascial Pain Syndrome	N/A
Completed	`NCT02417779` - Cutaneous Microcirculation After Extracorporeal Shock Wave Therapy	N/A
Completed	`NCT02417805` - Cutaneous Microcirculation After Remote Ischemic Preconditioning	N/A
Completed	`NCT02417818` - Cutaneous Microcirculation After Plasma Therapy	N/A
Completed	`NCT03662997` - Clinical Study to Compare 3 Multi-Layered Foam Dressings for the Management of Chronic Wounds	N/A
Not yet recruiting	`NCT04132635` - A Trial to Evaluate the Combination Efficacy of Artificial Dermis and Growth Factor in Chronic Wounds Ulcer	N/A
Withdrawn	`NCT01646502` - Treatment of Chronic Wound Biofilms	N/A
Recruiting	`NCT05342740` - Study of Biomarkers in Diabetic Chronic Wounds
Suspended	`NCT02577120` - Wound Healing Endpoint and Recurrence	Phase 4
Recruiting	`NCT06185465` - Effectiveness and Safety of Using Prontosan to Treat Bacterial Biofilm	N/A
Completed	`NCT04514783` - Healthy Tissue Preservation During Wound Debridement by Using Debritom+ Micro Water Jet Technology	N/A
Terminated	`NCT01429519` - Efficacy of RPh201 Applied Topically for the Treatment of Hard to Heal Chronic Ulcerated Wounds	Phase 1/Phase 2
Not yet recruiting	`NCT05974228` - Bioglass Wound Dressing in Treatment of Chronic Wound in Different Stage：a Randomized Controlled Trial	N/A
Recruiting	`NCT05414916` - Pain Relief Strategies for Dressing Change in Chronic Wounds
Recruiting	`NCT04019639` - Efficacy of Paste Type Acellular Dermal Matrix(CG Paste) in Chronic Wound Healing	N/A
Completed	`NCT05810649` - Local Injection for the Treatment of Chronic Wounds and Pain Caused by Chronic Wounds	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.